Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ryoko Sato-Ishida"'
Autor:
Michihiko Kitayama, Makoto Watanabe, Taketsugu Tsuchiya, Minako Oda, Kouji Kajinami, Takaaki Takamura, Yasuyuki Kawai, Hironobu Akao, Ryuhei Saito, Ryoko Sato-Ishida
Publikováno v:
Atherosclerosis. 263:192-197
Despite advances in the treatment of peripheral artery disease (PAD), cardiovascular events and death rates remain high. This study aimed at identifying markers of outcome in patients with PAD undergoing endovascular therapy (EVT).Consecutive patient
Autor:
Ryuichi Hasegawa, Hironobu Akao, Keiko Maekawa, Tatsuro Ishida, Yoshiro Saito, Kenji Takeda, Kouichi Kurose, Takashi Tanimoto, Keijiro Saku, Takashi Yamano, Kouji Kajinami, Kimie Sai, Aya Shiraki, Masafumi Ueno, Shusuke Yagi, Shunichi Miyazaki, Koichi Sugamura, Mizuho Iwadare, Ken-ichi Hirata, Masataka Sata, Yasuyuki Kawai, Koichi Node, Jun-ichi Oyama, Takuya Imatoh, Takashi Akasaka, Ryoko Sato-Ishida, Takeshi Soeki, Hisao Ogawa, Y. Matsuzawa
Publikováno v:
Drug Metabolism and Pharmacokinetics. 31:467-470
Statin-related myopathy (SRM) is a clinically important adverse reaction. Recent pharmacogenetic research, mainly in non-Asian populations, have indicated clinical relevance of some of genetic biomarkers to SRM, but predictive markers for SRM in Asia
Publikováno v:
Drug Design, Development and Therapy
Inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, known as statins, have revolutionized the treatment of hypercholesterolemia and coronary artery disease prevention. However, there are considerable issues regarding statin safet